FEATURED

Controversy Remains Regarding TARGIT-A Results

Results from the international, noninferiority phase 3 TARGIT-A trial continue to be questioned by researchers and patient advocacy groups.

New Approvals Shift CLL Treatment

The approvals of obinutuzumab, ibrutinib, and idelalisib provide clinicians with new treatment options for patients with CLL.

Genetic Counseling Could Affect PCa Treatment

A new study highlights the need for genetic counseling, which could help determine treatment options for certain patients.

Colorectal Cancer Survival Outcomes

This study evaluates survival outcomes of intensive surveillance after CRC resection.

Breast-conservation: APBI vs. Interstitial Brachytherapy

Is targeting the entire breast necessary to the success of adjuvant radiotherapy?

ASCO: CSF Clinical Practice Guideline Update

ASCO updates Clinical Practice Guidelines for the use of hematopoietic colony-stimulating factors (CSFs).

Older Pts. May Prefer Privacy

Sharing health information about an older patient with family may have unintended consequences.

Drug Showcase: MOZOBIL (plerixafor)

Indicated for non-Hodgkin’s lymphoma and multiple myeloma.

Deferred Therapy Sometimes Better

Delaying use of new targeted therapies may result in improved quality of life without adversely affecting outcomes.

XTANDI Practice and Patient Resources

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Viewpoints

Partial Breast Irradiation Provides "Excellent Long-term Local Control"

Partial Breast Irradiation Provides "Excellent Long-term Local Control"

Is targeting the entire breast necessary to the success of adjuvant radiotherapy?

ASCO Releases Guideline Updates for the Use of Colony-stimulating Factors

ASCO Releases Guideline Updates for the Use of Colony-stimulating Factors

ASCO updates Clinical Practice Guidelines for the use of hematopoietic colony-stimulating factors (CSFs).

Feature Articles

TARGIT-A: Challenges in Shifting the Paradigm of Whole Breast Radiation

TARGIT-A: Challenges in Shifting the Paradigm of Whole Breast Radiation

Results from the international, noninferiority phase 3 TARGIT-A trial continue to be questioned by researchers and patient advocacy groups.

New Drug Approvals Bring Hope, Challenges in the Treatment of Chronic Leukemia

New Drug Approvals Bring Hope, Challenges in the Treatment of Chronic Leukemia

The approvals of obinutuzumab, ibrutinib, and idelalisib provide clinicians with new treatment options for patients with chronic lymphocytic leukemia (CLL).

Featured Videos

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs